A detailed history of Wolverine Trading, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 11,611 shares of IONS stock, worth $394,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,611
Previous 21,328 45.56%
Holding current value
$394,890
Previous $1.02 Million 54.23%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$40.06 - $51.86 $389,263 - $503,923
-9,717 Reduced 45.56%
11,611 $465,000
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $338,292 - $442,703
9,281 Added 77.04%
21,328 $1.02 Million
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $107,260 - $136,659
2,552 Added 26.88%
12,047 $522,000
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $411,988 - $490,226
9,495 New
9,495 $480,000
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $42,282 - $57,950
1,651 Added 1.54%
108,529 $3.31 Million
Q3 2021

Nov 12, 2021

SELL
$33.54 - $40.55 $136,507 - $165,038
-4,070 Reduced 3.67%
106,878 $3.59 Million
Q2 2021

Aug 06, 2021

BUY
$34.54 - $47.25 $46,179 - $63,173
1,337 Added 1.22%
110,948 $4.39 Million
Q1 2021

May 14, 2021

BUY
$42.51 - $63.78 $3.92 Million - $5.88 Million
92,142 Added 527.46%
109,611 $4.9 Million
Q4 2020

Feb 12, 2021

SELL
$45.3 - $60.27 $8.3 Million - $11 Million
-183,120 Reduced 91.29%
17,469 $999,000
Q3 2020

Nov 13, 2020

BUY
$47.45 - $62.95 $4.76 Million - $6.32 Million
100,324 Added 100.06%
200,589 $9.73 Million
Q2 2020

Aug 13, 2020

SELL
$46.85 - $61.05 $11,806 - $15,384
-252 Reduced 0.25%
100,265 $5.96 Million
Q1 2020

May 11, 2020

BUY
$41.6 - $63.4 $1.11 Million - $1.7 Million
26,768 Added 36.3%
100,517 $4.85 Million
Q4 2019

Feb 12, 2020

SELL
$53.85 - $65.27 $1.21 Million - $1.46 Million
-22,391 Reduced 23.29%
73,749 $4.45 Million
Q3 2019

Nov 14, 2019

BUY
$59.06 - $72.15 $805,342 - $983,837
13,636 Added 16.53%
96,140 $5.68 Million
Q2 2019

Aug 20, 2019

SELL
$62.09 - $86.14 $214,645 - $297,785
-3,457 Reduced 4.02%
82,504 $5.3 Million
Q1 2019

May 15, 2019

SELL
$52.92 - $81.17 $1.13 Million - $1.73 Million
-21,274 Reduced 19.84%
85,961 $6.98 Million
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $430,100 - $590,458
9,917 Added 10.19%
107,235 $5.51 Million
Q3 2018

Nov 14, 2018

BUY
$42.88 - $53.7 $3.49 Million - $4.37 Million
81,335 Added 508.88%
97,318 $5.02 Million
Q1 2018

May 15, 2018

BUY
$44.08 - $55.05 $236,136 - $294,902
5,357 Added 50.41%
15,983 $705,000
Q4 2017

Feb 14, 2018

SELL
$50.3 - $64.39 $1.08 Million - $1.38 Million
-21,482 Reduced 66.91%
10,626 $534,000
Q3 2017

Nov 15, 2017

BUY
$45.56 - $59.57 $1.46 Million - $1.91 Million
32,108
32,108 $1.63 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.